Claudin-3 inhibits tumor-induced lymphangiogenesis via regulating the PI3K signaling pathway in lymphatic endothelial cells

Sci Rep. 2022 Oct 19;12(1):17440. doi: 10.1038/s41598-022-22156-6.

Abstract

Claudin-3 is a tight junction protein that has often been associated with the progression and metastasis of various tumors. Here, the role of claudin-3 in tumor-induced lymphangiogenesis is investigated. We found an increased lymphangiogenesis in the B16F10 tumor in claudin-3 knockout mice, accompanied by augmented melanoma cell metastasis into sentinel lymph nodes. In vitro, the overexpression of claudin-3 on lymphatic endothelial cells inhibited tube formation by suppressing cell migration, resulting in restricted lymphangiogenesis. Further experiments showed that claudin-3 inhibited lymphatic endothelial cell migration by regulating the PI3K signaling pathway. Interestingly, the expression of claudin-3 in lymphatic endothelial cells is down-regulated by vascular endothelial growth factor C that is often present in the tumor microenvironment. This study indicates that claudin-3 plays an important role as a signaling molecule in lymphatic endothelial cell activity associated with tumor lymphangiogenesis, which may further contribute to melanoma metastasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Claudin-3* / genetics
  • Claudin-3* / metabolism
  • Endothelial Cells / metabolism
  • Lymphangiogenesis
  • Lymphatic Metastasis / pathology
  • Lymphatic Vessels* / metabolism
  • Melanoma* / pathology
  • Mice
  • Phosphatidylinositol 3-Kinases / metabolism
  • Signal Transduction
  • Tumor Microenvironment
  • Vascular Endothelial Growth Factor C / metabolism

Substances

  • Claudin-3
  • Phosphatidylinositol 3-Kinases
  • Vascular Endothelial Growth Factor C